A-431 + EGF Whole Cell Lysate: sc-2202

The A-431 + EGF Whole Cell Lysate is produced from the A-431 cell line, an epidermoid carcinoma cell line derived from a lesion on the skin of an 85-year-old female. This lysate is specifically prepared from cells that have been exposed to Epidermal Growth Factor (EGF), a critical molecule that stimulates cell growth and differentiation via the activation of the epidermal growth factor receptor (EGFR), which is abundantly expressed in A-431 cells. When EGF is introduced to these cells, it triggers a cascade of signaling pathways, making this lysate an excellent resource for studying cellular responses to external growth signals. Researchers leverage the A-431 + EGF Whole Cell Lysate in various research domains, notably in the analysis of signal transduction pathways and the examination of protein interactions and dynamics. By providing a snapshot of the cellular environment after EGF stimulation, the lysate enables scientists to dissect the complex biochemical events that govern cell behavior, including proliferation and survival. Additionally, it serves as a crucial tool in proteomic studies where understanding the modulation of protein phosphorylation and other post-translational modifications is key. This lysate is thus pivotal in advancing our knowledge of cell biology, contributing significantly to the broader scientific understanding of how cells communicate and respond to environmental cues.